We aim to share the knowledge gained from clinical research studies, as well as the published clinical care guidelines, in ways that can be easily understood by patients and their families. We also aim to find better ways to educate patients, family, clinicians, and health care providers about the impact of maternal IBD and IBD therapies on maternal and fetal/neonatal outcomes.

INTERESTED or HAVE QUESTIONS?  Wish to participate or volunteer?

If you are interested in participating in any of the studies, please email us at Vivian.Huang@sinaihealth.ca (Toronto) or HuangIBDclinic@sinaihealth.ca   

1) Pain Management in Patients with Inflammatory Bowel Disease during Pregnancy

We are looking to understand how Inflammatory Bowel Disease (IBD) affects pregnancy, the things patients may use to manage their symptoms during this time period, and how we might be better able to help patients manage their symptoms during pregnancy.  Steroids and immunosuppressants are currently used as standard therapies for IBD, but it is our experience that some patients have also reported symptomatic relief from the use of alternative medicine.  The purpose of this study is to assess the use of pain killers, complimentary alternative medicine (homeopathy, herbal remedies, acupuncture, aromatherapy, hypnotherapy, naturopathy) and cannabis in patients with IBD before and during pregnancy.

If you are considering pregnancy, are pregnant, or recently pregnant, and are interested to provide your anonymous insight into pain management and IBD and pregnancy, please complete the short anonymous survey. This study is being conducted out of Mount Sinai Hospital, Toronto.

 

 

 

2)  Physician and Patient Perceptions and Attitudes Regarding Aspirin for the Prevention of Preeclampsia in Women with Inflammatory Bowel Disease

We are investigating physician and patient thoughts and attitudes with regards to Aspirin for the prevention of preeclampsia in women with IBD.

If you are preconception, pregnant, or postpartum, and are interested to provide your anonymous insight into the use of aspirin for the prevention of preeclampsia in women with IBD, please complete the short (less than 20 to 30 minutes) anonymous survey.  This study is being conducted out of Mount Sinai Hospital, Toronto.  If you wish to learn more or to participate in this research, please contact Dr. Hanna at Youstina.hanna@mail.utoronto.ca or Dr. Huang at HuangIBDclinic@sinaihealth.ca

 

 

 

3) Preconception and Pregnancy in IBD – COVID-19 Assessment

We are looking to assess the impact of COVID-19 on IBD patients in relation to pregnancy.  Patients who are considering pregnancy, are pregnant, or recently pregnant, and are interested to provide your anonymous insight on the impact of COVID-19 on IBD and pregnancy can complete the anonymous survey (approximately 15 to 20 minutes) for this research study at this link anonymous survey.